Delivery Order SPE2DB20D6037-SPE2DB24FTXA8
Award Date
9/16/24
Potential Completion Date
9/17/24
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4562048894 - Procainamide 1 Gram/10 ML Vial 10ML. The contract has a ceiling value of $1,530.61 and an ultimate completion date of August 21, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued up to $499,999,999, which supports the recurring...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The award is for the supply of 4,565,516,936 units of the pharmaceutical drug procainamide 1 gram/10 mL vial, 10 mL, at a firm fixed price of $1,530.61. The contract has no set-aside designation and is intended to fulfill the recurring medical supply needs of Department of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 4567916216 - Procainamide 1 Gram/10 ML Vial 10 ML, a pharmaceutical product, to support the medical supply needs of military health facilities. The contract has a ceiling value of $3,132.00 and an ultimate completion date of April 3, 2025. DMS Pharmaceutical Group Inc. also holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,155.02, is for the delivery of Procainamide 1 gram/10 ml vial (10 ml) to support the recurring medical supply needs of military health facilities. The delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $8,776.50 contract is for the delivery of 4,558,205,554 vials of 1 gram/10 ml procainamide, a prescription medication. The award is part of a larger single-award indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,530.61 firm fixed-price delivery order is for the supply of 4567197181 procainamide 1 gram/10 ml vials. The award is not associated with a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm...
This federal contract award, valued at $1,605.15, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Procainamide Hydrochloride Injection USP, a pharmaceutical product, to support the medical supply needs of military health facilities worldwide. This delivery order is part of a larger indefinite delivery contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,246.42, covers the procurement of Procainamide Hydrochloride, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract is not associated with any set-aside designation, allowing DMS...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,277.81 contract is for the delivery of Procainamide Hydrochloride, a pharmaceutical product, with a completion date of December 13, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is valued at $5,470.89 and has an ultimate completion date of May 1, 2025. The contract was awarded by the Defense Logistics Agency (DLA) to provide procainamide hydrochloride, a pharmaceutical product, to support the medical supply needs of federal agencies. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery...